Clinical Trial Update: Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of a fixed-dose Timolol/Dorzolamide therapy on ocular autoregulation in open-angle glaucoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Timolol/Dorzolamide fixed-dose combination (timolol/dorzolamide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Open Angle Glaucoma | Phase 4 | Status: COMPLETED